IndianaLifeScience.com

BioHistory Moment: Food Additives Amendments passed

On September 6, 1958, The Food Additives Amendments were passed, requiring that food additives, including preservatives, emulsifiers, and other functional additives, be subject to premarket testing.

Today, the FDA must review the safety of food and color additives before manufacturers and distributors can market them. To initiate this review, the FDA requires sponsors to submit a petition or notification that includes test data demonstrating the safety of the intended use of the substance.

More...

Learn about University of Iowa Research Park BioVentures Center

University of Iowa’s Oakdale Research Park.

The Research Park/BioVentures Center, also known as the University of Iowa’s Oakdale Campus, is conveniently located on Highway 965 near Interstates 80 and 380 and U.S. Highways 16 and 218. The Park is in the fast-growing community of Coralville, about 10 minutes from the main UI campus of Iowa City, 15 minutes from commercial airlines at the Eastern Iowa Regional Airport in Cedar Rapids and 10 minutes from charter and corporate aircraft at the Iowa City Municipal Airport.

Learn about biotechnology, medical device and pharmaceutical facilities available for sale, lease or sublease in Indiana, regionally or nationwide.

More...

(Advertising)

Industry News...

Free News Release Posting & Archiving Service

Mayo Clinic study finds mild cognitive impairment is more common in men A Mayo Clinic study found that the prevalence of mild cognitive impairment was 1.5 times higher in men than in women. The research also showed a prevalence rate of 16 percent in the population-based study of individuals aged 70-89 without dementia who live in Olmsted County, Minn.
Mayo Clinic September 06, 2010
MedImmune receives complete response letter on motavizumab MedImmune announced that it has received a second complete response letter on motavizumab from the FDA which requested evidence from an additional clinical trial that supports a satisfactory risk/benefit profile in the population(s) for which the prophylaxis indication is being requested.
MedImmune, LLC. September 05, 2010
European Commission issues positive decision for approval of Seroquel XR AstraZeneca announced the European Commission issued a positive decision for the approval of once-daily SEROQUEL XR Extended Release Tablets as an add-on treatment of major depressive episodes in patients with Major Depressive Disorder who had sub-optimal response to antidepressant monotherapy.
AstraZeneca September 02, 2010
New England Journal of Medicine reports Xpert MTB/RIF a faster Tuberculosis test New England Journal of Medicine reports Xpert MTB/RIF a faster, more Cepheid announced that its Xpert(R) MTB/RIF test was the subject of a study published in the latest edition of the New England Journal of Medicine (NEJM), "Rapid Molecular Detection of Tuberculosis and Rifampin Resistance."
Cepheid September 02, 2010
Allergan resolves investigation of past sales and marketing practices related to BOTOX(R) Allergan announced a resolution with the U.S. Department of Justice regarding Allergan's past U.S. sales and marketing practices relating to therapeutic uses of BOTOX. Allergan pled guilty to a single misdemeanor "misbranding" charge covering the period 2000 through 2005 and will pay $375 million.
Allergan, Inc. September 01, 2010

More... | Submit News Release | Advertising...

New Job Postings...

Free Job Posting Trial Offer

Head of Medical Affairs Operations Seattle Genetics, Inc. (WA)
Molecular & FISH Technologist CellNetix Pathology and Laboratories (WA)
Postdoctoral Research Associate Benaroya Research Institute (WA)
Animal Technician I Benaroya Research Institute (WA)
Research Technician I/II Benaroya Research Institute (WA)

More... | Job Advertising... | About Job Postings...

New Facilities Available...

ATC clean room constructors...validation guaranteed!

890 Embarcadero Road Property -- West Sacramento, CA
Icogenex Biotech Incubator -- Seattle, WA
Biotech and Life Sciences Incubator -- Seattle, WA
University of Iowa Oakdale Research Park Biotech Building -- Coralville, IA
University of Iowa Oakdale Research Park BioVentures Center -- Coralville, IA

More... | Facility Advertising...

Upcoming Events...

09/12/2010: 2010 Agricultural Biotechnology International Conference
09/13/2010: The Future of Bio-Based Chemicals – Inception to Marketplace
09/13/2010: SEB Food Security and Safety Symposium
09/13/2010: ADAPT 2010
09/13/2010: Biotechnology: Science for Managers

More... | Submit Event | Event Advertising...

Learn About Indiana's BioHistory

Why is there a life science industry in Indiana? Is the industry growing? What do other states have?

Through Indiana BioHistory, you can learn about the scientists, institutions, political leaders, and significant events that have shaped and are still shaping the biotechnology, medical device and life science industry in Indiana.

More...

BioEvolution Posters

More...

September: Ovarian Cancer Awareness Month

In women age 35-74, ovarian cancer is the fifth leading cause of cancer-related deaths. An estimated one woman in 58 will develop ovarian cancer during her lifetime. The American Cancer Society estimates that in 2008, there will be 21,650 new cases of ovarian cancer and 15,520 women will die from ovarian cancer.

The National Ovarian Cancer Coalition (NOCC) is dedicated to raising awareness and increasing education about ovarian cancer. Established in 1995, the organization is committed to improving the survival rate and quality of life for women with this cancer.

More...